Fueled by innovation and rising chronic diseases, organoids and spheroids in Asia Pacific revolutionize personalized medicine ...

Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor ...

A Phase I clinical trial led by researchers at University of California San Diego School of Medicine has demonstrated the long-term safety and feasibility of neural stem cell transplantation for ...

Russia claims to have developed its own cancer vaccine, which could be one of the biggest medical breakthroughs of the ...

Russia has developed an mRNA cancer vaccine and plans to release it publicly in early 2025, free of charge. Pre-clinical trials show it inhibits tumor growth and spread. Researchers are also using AI ...

In an official announcement the Russian Health Ministry said that a cancer vaccine will be launched in 2025 and will be ...

In what experts are calling a landmark breakthrough, Russia has announced the development of its first mRNA-based cancer ...

Hui Feng, MD, PhD, associate professor of pharmacology, physiology & biophysics and medicine at Boston University Chobanian & Avedisian School of Medicine, has received an RO1 grant from the National ...

focusing on the design of anti-tumor nanoparticles to target tumor endothelial cells and noncellular blood components. Surface chemistry is another key determinant for nanoparticle performance.

Summary: Researchers have found that a ketogenic diet boosts CAR T cell therapy effectiveness by enhancing tumor control and survival in mice with lymphoma. The key is beta-hydroxybutyrate (BHB), a ...

To test their guards in a living organism, the researchers then took beta cells derived from stem cells and implanted them ...